- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03919305
Cerebral Venous Thrombosis Cohort Study in China Mainland (CCC)
April 16, 2019 updated by: Ji Xunming,MD,PhD, Capital Medical University
This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland.
Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.
Study Overview
Status
Not yet recruiting
Detailed Description
cerebral venous thrombosis (CVT) is caused by a clot in the cerebral vein, which resulted in an obstruction of the blood outflow.
CVT mainly includes cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis.
However, the epidemiological features of CVT in China mainland remained obscure.
This study was aimed to establish a multicenter cohort recruiting patients with CVT across 31 provinces and municipalities in China mainland.
Clinical features,natural history of the diseases and current therapeutic situations will be analyzed to reveal the epidemiological features of CVT.
Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.
Patients will be followed-up at 1, 3, 6, 12 months from baseline to evaluate the clinical prognosis and therapeutic outcomes.
Study Type
Observational
Enrollment (Anticipated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Min Li, MD, PhD
- Phone Number: +86-18701519698
- Email: 812879698@qq.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis.
Description
Inclusion Criteria:
• Cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis diagnosed by digital subtraction angiography (DSA), magnetic resonance venography (MRV), computed tomography venography (CTV) or high-resolution magnetic resonance imaging (HR-MRI).
Exclusion Criteria:
• None of the patient, trustee or immediate family members signed the informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death rate
Time Frame: 1 year from baseline
|
A combination of death form of all causes
|
1 year from baseline
|
Functional independence
Time Frame: 1 year from baseline
|
Defined as modified Rankin score (0-5) equal to or lower than 2
|
1 year from baseline
|
Recurrence of cerebral venous sinus thrombosis, deep cerebral venous thrombosis and cortical vein thrombosis
Time Frame: 1 year from baseline
|
Diagnosed by DSA, MRV, CTV or HR-MRI
|
1 year from baseline
|
Incidence of hemorrhagic complication
Time Frame: 1 year from baseline
|
Extracranial hemorrhage (fall in hemoglobin of 2 gram/dl or more within 48 hours) or intracranial hemorrhage
|
1 year from baseline
|
Incidence of sinus wall rupture
Time Frame: 1 year from baseline
|
1 year from baseline
|
|
Incidence of acute ischemic stroke
Time Frame: 1 year from baseline
|
1 year from baseline
|
|
Incidence of acute myocardial infarction
Time Frame: 1 year from baseline
|
1 year from baseline
|
|
Incidence of pulmonary embolism
Time Frame: 1 year from baseline
|
1 year from baseline
|
|
Incidence of deep venous thrombosis
Time Frame: 1 year from baseline
|
1 year from baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of epilepsy
Time Frame: 1 year from baseline
|
1 year from baseline
|
Incidence of allergic reaction
Time Frame: 1 year from baseline
|
1 year from baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Xunming Ji, MD, PhD, Xuanwu Hospital, Beijing
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2019
Primary Completion (Anticipated)
May 31, 2028
Study Completion (Anticipated)
May 31, 2029
Study Registration Dates
First Submitted
April 3, 2019
First Submitted That Met QC Criteria
April 16, 2019
First Posted (Actual)
April 18, 2019
Study Record Updates
Last Update Posted (Actual)
April 18, 2019
Last Update Submitted That Met QC Criteria
April 16, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CVT-China
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Venous Sinus Thrombosis
-
University Hospital, AkershusUniversity of Oslo; Oslo University Hospital; Rigshospitalet, Denmark; University... and other collaboratorsRecruitingCerebral Vein Thrombosis | Cerebral Venous Sinus ThrombosisNorway
-
Capital Medical UniversityThe First Affiliated Hospital of Zhengzhou University; Guizhou Provincial People... and other collaboratorsCompletedCerebral Vein Thrombosis | Cerebral Venous Sinus ThrombosisChina
-
Ji Xunming,MD,PhDRecruitingCerebral Venous Sinus ThrombosisChina
-
Capital Medical UniversityUnknownCerebral Venous Sinus Thrombosis | BatroxobinChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingMagnetic Resonance Imaging | Cerebral Venous Sinus Thrombosis | Computer TomographgyChina
-
Centre Hospitalier Universitaire, AmiensCompletedStroke | Venous Thromboses | Superior Sagittal Sinus ThrombosisFrance
-
Capital Medical UniversityUnknownPapilledema | Cerebral Venous Sinus Thrombosis | CSF Pressure IncreasedChina
-
University of British ColumbiaCompleted
-
Isfahan University of Medical SciencesUnknownCerebral Venous ThrombosisIran, Islamic Republic of
-
Capital Medical UniversityUnknownCerebral Venous ThrombosisChina